Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.

MLA

Bergeman, Auke T., et al. “Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.” Circulation, vol. 148, no. 25, Dec. 2023, pp. 2029–37. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.123.064786.

APA

Bergeman, A. T., Lieve, K. V. V., Kallas, D., Bos, J. M., Rosés I Noguer, F., Denjoy, I., Zorio, E., Kammeraad, J. A. E., Peltenburg, P. J., Tobert, K., Aiba, T., Atallah, J., Drago, F., Batra, A. S., Brugada, R., Borggrefe, M., Clur, S.-A. B., Cox, M. G. P. J., Davis, A., … van der Werf, C. (2023). Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia. Circulation, 148(25), 2029–2037. https://doi.org/10.1161/CIRCULATIONAHA.123.064786

Chicago

Bergeman, Auke T, Krystien V V Lieve, Dania Kallas, J Martijn Bos, Ferran Rosés I Noguer, Isabelle Denjoy, Esther Zorio, et al. 2023. “Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.” Circulation 148 (25): 2029–37. doi:10.1161/CIRCULATIONAHA.123.064786.